Shukun raises RMB200M series B round for AI diagnostics

Medical artificial intelligence company Shukun (Beijing) Network Technology Co. Ltd. (Beijing, China) completed a RMB200 million ($29.6 million) series B round led by China Creation Ventures. Two A round investors, Morningside Venture Capital and Huagai Capital, participated in the round, along with angel investor Marathon Venture Partners.

Shukun is developing AI platforms for diagnosis, research and hospital management. Its AI software platform for cardiovascular and cerebrovascular diseases uses medical imaging analysis for diagnosis, 3-D reconstruction, hemodynamic analysis and surgical planning, and is deployed in more than 100 hospitals across China...